Parkman Healthcare Partners LLC Reviva Pharmaceuticals Holdings, Inc. Call Options Transaction History
Parkman Healthcare Partners LLC
- $678 Million
- Q2 2024
Call Options
0 transactions
Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
---|
Others Institutions Holding RVPH
# of Institutions
37Shares Held
6.85MCall Options Held
256KPut Options Held
77.1K-
Woodline Partners LP San Francisco, CA1.59MShares$2.18 Million0.02% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny1.24MShares$1.7 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.03MShares$1.4 Million0.0% of portfolio
-
Schonfeld Strategic Advisors LLC New York, NY1.01MShares$1.39 Million0.01% of portfolio
-
Sabby Management, LLC Upper Saddle River, NJ237KShares$324,68519.92% of portfolio
About REVIVA PHARMACEUTICALS HOLDINGS, INC.
- Ticker RVPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 20,442,900
- Market Cap $28M
- Description
- Reviva Pharmaceuticals Holdings, Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes next-generation therapeutics for diseases targeting unmet medical needs in the areas of central nervous system, respiratory, cardiovascular, metabolic, and inflammatory diseases. The company's lead product candidate is RP506...